Fallbericht
PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT
ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY · 2014
DOI: 10.26574/rojced.2017.4.3.126 ↗Kurz gefasst
Fallbericht in der Zeitschrift ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2014). PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT. ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY. https://doi.org/10.26574/rojced.2017.4.3.126
Vancouver
PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT. ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2014. doi:10.26574/rojced.2017.4.3.126
BibTeX
@article{euvimed2014,
title = {PEGYLATED LIPOSOMAL ENCAPSULATED DOXORUBICIN AND BRENTUXIMAB VEDOTIN IN STAGE IIB MYCOSIS FUNGOIDES – A CASE REPORT},
journal = {ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY},
year = {2014},
doi = {10.26574/rojced.2017.4.3.126}
}
EUVIMED